JP2019507113A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019507113A5 JP2019507113A5 JP2018534626A JP2018534626A JP2019507113A5 JP 2019507113 A5 JP2019507113 A5 JP 2019507113A5 JP 2018534626 A JP2018534626 A JP 2018534626A JP 2018534626 A JP2018534626 A JP 2018534626A JP 2019507113 A5 JP2019507113 A5 JP 2019507113A5
- Authority
- JP
- Japan
- Prior art keywords
- biodegradable
- disease
- antigen
- subject
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021105106A JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2023132166A JP7730867B2 (ja) | 2016-01-04 | 2023-08-14 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2025136021A JP2025181835A (ja) | 2016-01-04 | 2025-08-18 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662274711P | 2016-01-04 | 2016-01-04 | |
| US62/274,711 | 2016-01-04 | ||
| PCT/US2017/012173 WO2017120222A1 (en) | 2016-01-04 | 2017-01-04 | Particles encapsulating fusion proteins containing linked epitopes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021105106A Division JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019507113A JP2019507113A (ja) | 2019-03-14 |
| JP2019507113A5 true JP2019507113A5 (https=) | 2020-02-06 |
| JP6904959B2 JP6904959B2 (ja) | 2021-07-21 |
Family
ID=59274014
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018534626A Active JP6904959B2 (ja) | 2016-01-04 | 2017-01-04 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2021105106A Active JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2023132166A Active JP7730867B2 (ja) | 2016-01-04 | 2023-08-14 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2025136021A Pending JP2025181835A (ja) | 2016-01-04 | 2025-08-18 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021105106A Active JP7333360B2 (ja) | 2016-01-04 | 2021-06-24 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2023132166A Active JP7730867B2 (ja) | 2016-01-04 | 2023-08-14 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
| JP2025136021A Pending JP2025181835A (ja) | 2016-01-04 | 2025-08-18 | 結合エピトープを含有する融合タンパク質を封入する粒子 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20190365656A1 (https=) |
| EP (1) | EP3400069A4 (https=) |
| JP (4) | JP6904959B2 (https=) |
| CA (1) | CA3009799A1 (https=) |
| IL (2) | IL260296B2 (https=) |
| WO (1) | WO2017120222A1 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9597385B2 (en) | 2012-04-23 | 2017-03-21 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| CN105188741A (zh) | 2013-04-03 | 2015-12-23 | 阿勒丁医疗公司 | 新型纳米颗粒组合物 |
| US10363288B2 (en) * | 2015-01-14 | 2019-07-30 | National Jewish Health | Insulin mimotopes and methods of using the same |
| GB201508025D0 (en) | 2015-05-11 | 2015-06-24 | Ucl Business Plc | Fabry disease gene therapy |
| CA3019005A1 (en) | 2016-05-18 | 2017-11-23 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| CN116970059A (zh) | 2016-12-22 | 2023-10-31 | 库尔生物制药有限公司 | T细胞调节性多聚体多肽及其使用方法 |
| US11851471B2 (en) | 2017-01-09 | 2023-12-26 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides and methods of use thereof |
| IL269000B2 (en) | 2017-03-15 | 2024-06-01 | Cue Biopharma Inc | Methods for modulating an immune response |
| CN111566214B (zh) * | 2017-07-06 | 2024-03-08 | 日东纺绩株式会社 | 抗人IgG4单克隆抗体及利用该抗体的人IgG4测定试剂 |
| EP3678677A4 (en) * | 2017-09-07 | 2021-06-16 | Cue Biopharma, Inc. | Antigen-presenting polypeptides and methods of use thereof |
| WO2019131769A1 (ja) * | 2017-12-26 | 2019-07-04 | 公立大学法人名古屋市立大学 | 新規抗ｐａｄ４抗体 |
| WO2019139896A1 (en) | 2018-01-09 | 2019-07-18 | Cue Biopharma, Inc. | Multimeric t-cell modulatory polypeptides and methods of use thereof |
| CN110041408B (zh) * | 2018-01-16 | 2021-05-18 | 华中科技大学 | 一种小分子多肽及其在制备防治帕金森综合症药物中的应用 |
| US11679146B2 (en) | 2018-06-05 | 2023-06-20 | Anji Pharmaceuticals Inc. | Compositions and methods for treating pancreatitis |
| ES3060550T3 (en) | 2018-06-13 | 2026-03-26 | Acraf | Peptides having inhibitory activity on muscarinic receptor m3 |
| US20230001010A1 (en) * | 2019-07-19 | 2023-01-05 | The Regents Of The University Of Michigan | Compositions and methods for treating autoimmune disorders |
| EP4138907A4 (en) * | 2020-04-20 | 2024-08-21 | The General Hospital Corporation | IMMUNOGENIC COMPOSITION OF CORONAVIRUS WITH EPITOPES HAVING HIGH NETWORK SCORE |
| TW202208395A (zh) | 2020-05-12 | 2022-03-01 | 美商信號生物製藥公司 | 多聚體ｔ細胞調節多肽及其使用方法 |
| IT202000010888A1 (it) * | 2020-05-13 | 2021-11-13 | Consiglio Nazionale Ricerche | Nanovescicole di mielina e loro impieghi |
| EP4211149A4 (en) | 2020-09-09 | 2024-10-09 | Cue Biopharma, Inc. | MULTIMERIC POLYPEPTIDES MODULATING MHC CLASS II T CELLS FOR THE TREATMENT OF TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF |
| GB202017119D0 (en) * | 2020-10-28 | 2020-12-09 | Oxford Vacmedix Uk Ltd | Polypeptides for cancer treatment |
| BR112023021222A2 (pt) | 2021-04-16 | 2024-01-16 | Cour Pharmaceuticals Dev Company Inc | Método de rastreamento de manutenção de tolerância imunológica |
| WO2022238689A1 (en) * | 2021-05-11 | 2022-11-17 | Oxford Vacmedix UK Limited | Vaccine formulation comprising recombinant overlapping peptides and native prtoeins |
| WO2023282293A1 (ja) * | 2021-07-07 | 2023-01-12 | 国立大学法人大阪大学 | ペプチド、及び組成物 |
| EP4419149A1 (en) | 2021-10-21 | 2024-08-28 | Cour Pharmaceuticals Development Company Inc. | Treatment of primary biliary cholangitis (pbc) with tolerizing nanoparticles |
| WO2023097260A1 (en) * | 2021-11-24 | 2023-06-01 | Cour Pharmaceuticals Development Company Inc. | Preparation of tolerizing nanoparticles for the treatment of peanut allergy |
| AU2023238308A1 (en) * | 2022-03-24 | 2024-10-10 | Julius-Maximilians-Universität Würzburg | Mhc ib-mediated islet-antigen-specific immunosuppression as a novel treatment for type 1 diabetes |
| CN119173251A (zh) | 2022-04-29 | 2024-12-20 | 库尔制药开发公司 | 用于克服治疗性载体和蛋白质的免疫原性的耐受性免疫修饰纳米粒子 |
| CN115541872A (zh) * | 2022-09-22 | 2022-12-30 | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 一种pd-l1检测试剂盒及其检测方法 |
| EP4604999A1 (en) | 2022-10-19 | 2025-08-27 | Cour Pharmaceuticals Development Company Inc. | Treatment of peanut allergy with tolerizing nanoparticles |
| CN115771883B (zh) * | 2022-11-28 | 2024-02-23 | 淮阴工学院 | 从酿酒酵母发酵液中提取的蛋白酶a在化学法合成纳米硒形貌控制和稳定性影响中的用途 |
| EP4687970A1 (en) | 2023-03-24 | 2026-02-11 | Cour Pharmaceuticals Development Company Inc. | Tolerizing immune modifying nanoparticles for myasthenia gravis treatment |
| AU2024275807A1 (en) | 2023-05-23 | 2025-12-11 | Cour Pharmaceuticals Development Company Inc. | Preparation of tolerizing nanoparticles for the treatment of primary biliary cholangitis |
| WO2024243524A1 (en) | 2023-05-25 | 2024-11-28 | Cour Pharmaceuticals Development Company Inc. | Treatment of type 1 diabetes (t1d) with tolerizing nanoparticles |
| WO2025027015A1 (en) * | 2023-08-01 | 2025-02-06 | Diamante Srl | Composition and methods for treating multiple sclerosis |
| WO2025043196A2 (en) * | 2023-08-24 | 2025-02-27 | The Trustees Of Indiana University | Anti-cancer peptides, and methods and uses thereof |
| WO2025199149A1 (en) | 2024-03-18 | 2025-09-25 | Cour Pharmaceuticals Development Company Inc. | Sting agonism for antigen specific tolerance |
| WO2026019942A2 (en) | 2024-07-16 | 2026-01-22 | Cour Pharmaceuticals Development Company Inc. | Tolerizing immune modifying nanoparticles for treatment of narcolepsy |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA004497B1 (ru) * | 1998-12-04 | 2004-04-29 | Байоджен, Инк. | Коровые антигенные частицы hbv с множественными иммуногенными компонентами, связанными посредством пептидных лигандов |
| US20020131960A1 (en) * | 2000-06-02 | 2002-09-19 | Michel Sadelain | Artificial antigen presenting cells and methods of use thereof |
| US20060222656A1 (en) * | 2005-04-01 | 2006-10-05 | University Of Maryland, Baltimore | MAGE-A3/HPV 16 peptide vaccines for head and neck cancer |
| EP2185195A2 (en) * | 2007-08-16 | 2010-05-19 | Tripep Ab | Immunogen platform |
| BR112012029611A2 (pt) * | 2010-05-21 | 2017-07-25 | Merrimack Pharmaceuticals Inc | proteína de fusão biespecífica, composição farmacêutica, método de tratamento de dano ao tecido em um indivíduo, método de promoção da regeração ou sobrevivência do tecido em um indivíduo e molécula de ácido nucleico |
| BR112013004288A2 (pt) * | 2010-08-23 | 2016-05-31 | Selecta Biosciences Inc | formas galênicas de múltiplos epítopos direcionados para indução de uma resposta imunológica a antigênios. |
| NZ717682A (en) * | 2012-02-16 | 2017-10-27 | Vlp Therapeutics Llc | Virus like particle composition |
| WO2013192532A2 (en) * | 2012-06-21 | 2013-12-27 | Northwestern University | Peptide conjugated particles |
| IL292567B2 (en) * | 2013-08-13 | 2025-06-01 | Univ Northwestern | Peptide conjugated particles |
| WO2017139498A1 (en) * | 2016-02-09 | 2017-08-17 | Cour Pharmaceuticals Development Company Inc. | Timps encapsulating japanese cedar pollen epitopes |
-
2017
- 2017-01-04 US US16/067,867 patent/US20190365656A1/en not_active Abandoned
- 2017-01-04 EP EP17736249.8A patent/EP3400069A4/en active Pending
- 2017-01-04 JP JP2018534626A patent/JP6904959B2/ja active Active
- 2017-01-04 CA CA3009799A patent/CA3009799A1/en active Pending
- 2017-01-04 IL IL260296A patent/IL260296B2/en unknown
- 2017-01-04 WO PCT/US2017/012173 patent/WO2017120222A1/en not_active Ceased
-
2021
- 2021-06-24 JP JP2021105106A patent/JP7333360B2/ja active Active
-
2023
- 2023-06-12 US US18/333,103 patent/US20240122864A1/en active Pending
- 2023-07-19 IL IL304580A patent/IL304580A/en unknown
- 2023-08-14 JP JP2023132166A patent/JP7730867B2/ja active Active
-
2025
- 2025-08-18 JP JP2025136021A patent/JP2025181835A/ja active Pending